Scholar Rock’s stock is due to drop by 7.49% following the news, according to pre-market estimates. CAMBRIDGE, Mass., March 16, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical ...
Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings ...
Cathie Wood’s ARK Invest is taking advantage of the recent dip in Tesla (TSLA) stock by purchasing 9,351 shares through its ...
The last few weeks of cascading share prices may be troublesome to most investors, but Cathie Wood doesn't mind buying during the deluge. The co-founder, CEO, and investment manager at Ark Invest has ...
Cathie Wood's Ark Invest sold $4.3 million worth of Meta shares on Wednesday, March 19, 2025, despite the company's Llama AI reaching 1 billion downloads.
Cathie Wood’s Ark Investment Management LLC is cutting its stake in Meta Platforms Inc. for the first time in around a year, ...
Scholar Rock (NASDAQ: SRRK ... announced that the National... TransCode Therapeutics, Inc. , the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today ...
1 Day SRRK -1.75% DJIA 0.08% S&P Mid Cap 400 -0.51% Health Care/Life Sciences 0.25% ...
As of 10:34:42 am GMT-4. Market open. Loading Chart for SRRK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback